SPOTLIGHT: Organogenesis plans expansion


With the help of state funds, Organogenesis is beefing up its operations in Massachusetts. The company, which makes regenerative medicine products, says it was persuaded to stay and grow in Massachusetts because of the state's new program to encourage the biotech field. Release | Report

Suggested Articles

What a difference a day makes in biotech.

A report out this week by PwC thinks that biotech could be in for a good year for deals as it sees the momentum from 2019 growing.

A drug developed at Temple restores a mechanism in brain cells that prevents the toxic buildup of the proteins amyloid beta and tau in Alzheimer's.